arrow
G

Geertruida L. E. Romeijn

University of Groningen
H指数:14
被引数:804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
2024-10-012
PRE
Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial)
2023-11-041
OA
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey
2023-02-151
OA
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry

Dupilumab在儿童特应性皮炎治疗中的日常实践: 来自BioDay注册表的28周临床和生物标志物结果

2022-12-0514
OA
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis Long-term Results From the Daily Practice BioDay Registry
2022-09-0123
OA
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

以患者为中心的dupilumab给药方案可成功减少持续控制的特应性皮炎的剂量

2022-07-2928
OA
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
2021-04-0158
OAAI
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry
2020-05-0537
OAAI
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema
2019-04-0820
OAAI